SUN-739 Next Generation AR Antagonists Increase Systemic Active Glucocorticoid Exposure by Altering Glucocorticoid Metabolism

Enzalutamide and apalutamide are potent next-generation androgen receptor (AR) antagonists used in metastatic and non-metastatic prostate cancer. Despite the increased survival benefits of these agents, resistance normally occurs and the disease transitions to its lethal form. We hypothesized that e...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Alyamani, Mohammad, Sharifi, Nima, Li, Jianbo, Patel, Mona, Berk, Michael, Taylor, Susan, Przybycin, Christopher, Posadas, Edwin M, Madan, Ravi, Gulley, James L, Rini, Brian I, Garcia, Jorgi A, Klein, Eric A
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Steroid Hormones and Receptors
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208944/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1762
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares